Search alternatives:
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
ms decrease » _ decrease (Expand Search), mean decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
ms decrease » _ decrease (Expand Search), mean decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
26701
Image_4_Reciprocal Relationship Between HDAC2 and P-Glycoprotein/MRP-1 and Their Role in Steroid Resistance in Childhood Nephrotic Syndrome.tif
Published 2019“…Compared to baseline, TSA treatment increased mRNA levels of P-gp and MRP-1 (fold change 7.51, 7.31, <sup>*</sup>p < 0.0001 in SRNS) and (fold change 3.49, 3.35, <sup>*</sup>p < 0.0001 in SSNS), respectively. It significantly decreased the level of HDAC2 (fold change 1.50, <sup>*</sup>p < 0.0001 in SRNS) (fold change 2.53, <sup>*</sup>p < 0.0001 in SSNS) patients.…”
-
26702
Image_3_Reciprocal Relationship Between HDAC2 and P-Glycoprotein/MRP-1 and Their Role in Steroid Resistance in Childhood Nephrotic Syndrome.tif
Published 2019“…Compared to baseline, TSA treatment increased mRNA levels of P-gp and MRP-1 (fold change 7.51, 7.31, <sup>*</sup>p < 0.0001 in SRNS) and (fold change 3.49, 3.35, <sup>*</sup>p < 0.0001 in SSNS), respectively. It significantly decreased the level of HDAC2 (fold change 1.50, <sup>*</sup>p < 0.0001 in SRNS) (fold change 2.53, <sup>*</sup>p < 0.0001 in SSNS) patients.…”
-
26703
Image_1_Reciprocal Relationship Between HDAC2 and P-Glycoprotein/MRP-1 and Their Role in Steroid Resistance in Childhood Nephrotic Syndrome.tif
Published 2019“…Compared to baseline, TSA treatment increased mRNA levels of P-gp and MRP-1 (fold change 7.51, 7.31, <sup>*</sup>p < 0.0001 in SRNS) and (fold change 3.49, 3.35, <sup>*</sup>p < 0.0001 in SSNS), respectively. It significantly decreased the level of HDAC2 (fold change 1.50, <sup>*</sup>p < 0.0001 in SRNS) (fold change 2.53, <sup>*</sup>p < 0.0001 in SSNS) patients.…”
-
26704
<i>Theileria annulata</i> parasites with M128I mutation in cytochrome B (<i>Ta</i>M128I) resist buparvaquone treatment.
Published 2024“…A clear right shift in dose-response curve resulted from decreased susceptibility of macrophages transformed by <i>Ta</i>M128I parasite compared to the wild type is detectable. …”
-
26705
Activity and Reactivity of Fe<sup>2+</sup> Cations in the Zeolite. Ab Initio Free-Energy MD Calculation of the N<sub>2</sub>O Dissociation over Iron-Exchanged Ferrierite
Published 2009“…The MD simulations show that the bivalent Fe<sup>2+</sup> cation can induce a local deformation of the zeolite framework, which cannot be observed experimentally. …”
-
26706
AOX inhibitor supresses growth of <i>T</i>. <i>hominis</i> cells inside the RK13 host cells at early meront stages of the infection, and affects the ability to infect by the spores...
Published 2022“…<p>Effects of the two clinically used anti-microsporidian drugs (albendazole, 350 nM; and fumagillin, 200 nM), and an inhibitor of the AOX Colletochlorin B (CCB, 50 μM) on progression of the parasite life cycle were tested in a synchronised time course of infection in <i>T</i>. …”
-
26707
Increased aggregation propensity enhances Pept-in antimicrobial potency by promoting Pept-in accumulation and IB formation.
Published 2023“…This figure is associated with data from <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0283674#pone.0283674.s009" target="_blank">S3 Table</a>. …”
-
26708
S1 Data -
Published 2025“…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
-
26709
S3 Data -
Published 2025“…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
-
26710
S2 Data -
Published 2025“…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
-
26711
S5 Data -
Published 2025“…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
-
26712
S6 Data -
Published 2025“…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
-
26713
S4 Data -
Published 2025“…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
-
26714
S7 Data -
Published 2025“…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
-
26715
TAp63 and p53 mutants display reduced proliferation in basal layers and reduced differentiation in upper layers of tubercle remnants.
Published 2014“…(F) Distribution of phenotypic strengths (n, normal; C1, intermediate; C2, strong) in lower jaw tubercles of wild-type, TAp63 mutant, p53 mutant and TAp63/p53 double mutant fish at an age of 50 days (upper panel) and 1 year (lower panel), determined via calcein staining (for example, see <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1004048#pgen-1004048-g008" target="_blank">Figure 8V,X</a>). …”
-
26716
Table_1_Durability of immune response after SARS-CoV-2 vaccination in patients with chronic liver disease.docx
Published 2023“…Within 30 days of booster immunization, the positive rates of nCoV NTAb and nCoV S-RBD in patients with CLD rapidly increased from 29.0% and 48.4% at the end of basic immunization to 95.2% and 90.5%, and maintained a high level (defined as the positive rate >50%) until 120 days when the positive rates of nCoV NTAb and nCoV S-RBD were still high at 79.5% and 87.2%, respectively. …”
-
26717
Table_3_Durability of immune response after SARS-CoV-2 vaccination in patients with chronic liver disease.docx
Published 2023“…Within 30 days of booster immunization, the positive rates of nCoV NTAb and nCoV S-RBD in patients with CLD rapidly increased from 29.0% and 48.4% at the end of basic immunization to 95.2% and 90.5%, and maintained a high level (defined as the positive rate >50%) until 120 days when the positive rates of nCoV NTAb and nCoV S-RBD were still high at 79.5% and 87.2%, respectively. …”
-
26718
Table_1_Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy.docx
Published 2022“…After a median follow-up of 69 months, the 5-year rate of DFS, BCSS, and LRR in the overall cohort was 90.2%, 97.4%, and 3.6%, respectively. …”
-
26719
Table_2_Durability of immune response after SARS-CoV-2 vaccination in patients with chronic liver disease.docx
Published 2023“…Within 30 days of booster immunization, the positive rates of nCoV NTAb and nCoV S-RBD in patients with CLD rapidly increased from 29.0% and 48.4% at the end of basic immunization to 95.2% and 90.5%, and maintained a high level (defined as the positive rate >50%) until 120 days when the positive rates of nCoV NTAb and nCoV S-RBD were still high at 79.5% and 87.2%, respectively. …”
-
26720
Targeting pan-caspase activation suppresses HIV-1 infection.
Published 2023“…Primary CD8-depleted PBMC were infected with HIV-1<sub>BAL</sub> for 6 days in the presence of 50uM indicated caspase inhibitors and analyzed for the accumulation of p24+/CD62L- populations (<b>A</b>) as well as the level of infection using intracellular p24 staining (<b>B</b>). …”